ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Orthopaedic Surgery

Top Orthopaedic Surgery Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RANDALL SMITH MD

Orthopaedic Surgery

4,989

$1.07M

274
61 are 65+

74%
patients receiving schedule two controlled substances

Avg: 23%

23%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 10%

$214
Average prescription price

Avg: $40

MARK AVART DO

Orthopaedic Surgery

2,167

$97.6K

251
82 are 65+

58%
patients receiving schedule two controlled substances

Avg: 23%

26%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 10%

$45
Average prescription price

Avg: $40

JAMES MACIELAK M. D.

Orthopaedic Surgery

2,077

$63.8K

316
179 are 65+

35%
patients receiving schedule two controlled substances

Avg: 23%

38%
patients receiving schedule three controlled substances

Avg: 36%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 10%

$31
Average prescription price

Avg: $40

JOHN ESTERHAI MD

Orthopaedic Surgery

2,035

$143K

150
39 are 65+

68%
patients receiving schedule two controlled substances

Avg: 23%

29%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 10%

$70
Average prescription price

Avg: $40

WILLIAM SIMON MD

Orthopaedic Surgery

1,652

$97.3K

137
86 are 65+

9%
patients receiving schedule two controlled substances

Avg: 23%

9%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 10%

$59
Average prescription price

Avg: $40

ANTHONY DIGIOIA MD

Orthopaedic Surgery

1,570

$50.2K

546
507 are 65+

5%
patients receiving schedule two controlled substances

Avg: 23%

39%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 10%

$32
Average prescription price

Avg: $40

BRUCE MENKOWITZ M.D.

Orthopaedic Surgery

1,500

$40.9K

319
245 are 65+

34%
patients receiving schedule two controlled substances

Avg: 23%

42%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 10%

$27
Average prescription price

Avg: $40

THOMAS CORCORAN M.D.

Orthopaedic Surgery

1,426

$34.6K

522
389 are 65+

4%
patients receiving schedule two controlled substances

Avg: 23%

23%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 10%

$24
Average prescription price

Avg: $40

STEVEN TRIANTAFYLLOU MD

Orthopaedic Surgery

1,425

$29.8K

355
259 are 65+

35%
patients receiving schedule two controlled substances

Avg: 23%

30%
patients receiving schedule three controlled substances

Avg: 36%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 10%

$21
Average prescription price

Avg: $40

JOHN BEIGHT M.D.

Orthopaedic Surgery

1,412

$75.4K

276
206 are 65+

31%
patients receiving schedule two controlled substances

Avg: 23%

26%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 10%

$53
Average prescription price

Avg: $40

JEFFREY MOGERMAN MD

Orthopaedic Surgery

1,389

$39.6K

242
170 are 65+

14%
patients receiving schedule two controlled substances

Avg: 23%

25%
patients receiving schedule three controlled substances

Avg: 36%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 10%

$29
Average prescription price

Avg: $40

CHRISTOPHER MCCLELLAN D.O.

Orthopaedic Surgery

1,325

$51.4K

371
287 are 65+

12%
patients receiving schedule two controlled substances

Avg: 23%

61%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 10%

$39
Average prescription price

Avg: $40

CURTIS GOLTZ D.O.

Orthopaedic Surgery

1,291

$33.6K

283
194 are 65+

21%
patients receiving schedule two controlled substances

Avg: 23%

46%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 10%

$26
Average prescription price

Avg: $40

PETER SOTOS MD

Orthopaedic Surgery

1,270

$25.6K

255
146 are 65+

24%
patients receiving schedule two controlled substances

Avg: 23%

53%
patients receiving schedule three controlled substances

Avg: 36%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 10%

$20
Average prescription price

Avg: $40

JOSE NAZAR MD

Orthopaedic Surgery

1,251

$33.5K

266
192 are 65+

20%
patients receiving schedule two controlled substances

Avg: 23%

29%
patients receiving schedule three controlled substances

Avg: 36%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 10%

$27
Average prescription price

Avg: $40

RONALD DISIMONE M.D.

Orthopaedic Surgery

1,246

$39.7K

282
197 are 65+

13%
patients receiving schedule two controlled substances

Avg: 23%

47%
patients receiving schedule three controlled substances

Avg: 36%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 10%

$32
Average prescription price

Avg: $40

RAYMOND DAHL D.O.

Orthopaedic Surgery

1,239

$34.5K

331
216 are 65+

33%
patients receiving schedule two controlled substances

Avg: 23%

44%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 10%

$28
Average prescription price

Avg: $40

STEPHEN LATMAN M.D.

Orthopaedic Surgery

1,232

$350K

50
0 are 65+

88%
patients receiving schedule two controlled substances

Avg: 23%

0%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 10%

$284
Average prescription price

Avg: $40

RICHARD GRANT MD

Orthopaedic Surgery

1,228

$126K

171
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 23%

18%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 10%

$103
Average prescription price

Avg: $40

MICHAEL JURENOVICH DO

Orthopaedic Surgery

1,222

$36.4K

182
82 are 65+

24%
patients receiving schedule two controlled substances

Avg: 23%

64%
patients receiving schedule three controlled substances

Avg: 36%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 10%

$30
Average prescription price

Avg: $40

JAMES REID MD

Orthopaedic Surgery

1,139

$24.4K

241
167 are 65+

22%
patients receiving schedule two controlled substances

Avg: 23%

37%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 10%

$21
Average prescription price

Avg: $40

EASWARAN BALASUBRAMANIAN MD

Orthopaedic Surgery

1,088

$39.1K

330
195 are 65+

25%
patients receiving schedule two controlled substances

Avg: 23%

17%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 10%

$36
Average prescription price

Avg: $40

MICHAEL TRANOVICH M.D.

Orthopaedic Surgery

1,071

$34.6K

329
228 are 65+

5%
patients receiving schedule two controlled substances

Avg: 23%

34%
patients receiving schedule three controlled substances

Avg: 36%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 10%

$32
Average prescription price

Avg: $40

SCOTT BARON MD

Orthopaedic Surgery

1,057

$32.9K

464
332 are 65+

13%
patients receiving schedule two controlled substances

Avg: 23%

41%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 10%

$31
Average prescription price

Avg: $40

STEPHEN LONGENECKER MD

Orthopaedic Surgery

1,038

$39.2K

371
334 are 65+

7%
patients receiving schedule two controlled substances

Avg: 23%

45%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 10%

$38
Average prescription price

Avg: $40

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank